Jia Coco Liu1, Ander Wilson, Loretta J Mickley, Francesca Dominici, Keita Ebisu, Yun Wang, Melissa P Sulprizio, Roger D Peng, Xu Yue, Ji-Young Son, G Brooke Anderson, Michelle L Bell. 1. From the aSchool of Forestry and Environmental Studies, Yale University, New Haven, CT; bDepartment of Biostatistics, T.H. Chan School of Public Health, Harvard University, Cambridge, MA; cSchool of Engineering and Applied Sciences, Harvard University, Cambridge, MA; dDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; and eDepartment of Environmental & Radiological Health Sciences, College of Veterinary Medicine & Biomedical Sciences, Colorado State University, Fort Collins, CO.
Abstract
BACKGROUND: The health impacts of wildfire smoke, including fine particles (PM2.5), are not well understood and may differ from those of PM2.5 from other sources due to differences in concentrations and chemical composition. METHODS: First, for the entire Western United States (561 counties) for 2004-2009, we estimated daily PM2.5 concentrations directly attributable to wildfires (wildfires-specific PM2.5), using a global chemical transport model. Second, we defined smoke wave as ≥2 consecutive days with daily wildfire-specific PM2.5 > 20 μg/m, with sensitivity analysis considering 23, 28, and 37 μg/m. Third, we estimated the risk of cardiovascular and respiratory hospital admissions associated with smoke waves for Medicare enrollees. We used a generalized linear mixed model to estimate the relative risk of hospital admissions on smoke wave days compared with matched comparison days without wildfire smoke. RESULTS: We estimated that about 46 million people of all ages were exposed to at least one smoke wave during 2004 to 2009 in the Western United States. Of these, 5 million are Medicare enrollees (≥65 years). We found a 7.2% (95% confidence interval: 0.25%, 15%) increase in risk of respiratory admissions during smoke wave days with high wildfire-specific PM2.5 (>37 μg/m) compared with matched non smoke wave days. We did not observe an association between smoke wave days with wildfire-specific PM2.5 ≤ 37 μg/mand respiratory or cardiovascular admissions. Respiratory effects of wildfire-specific PM2.5 may be stronger than that of PM2.5 from other sources. CONCLUSION: Short-term exposure to wildfire-specific PM2.5was associated with risk of respiratory diseases in the elderly population in the Western United States during severe smoke days. See video abstract at, http://links.lww.com/EDE/B137.
BACKGROUND: The health impacts of wildfire smoke, including fine particles (PM2.5), are not well understood and may differ from those of PM2.5 from other sources due to differences in concentrations and chemical composition. METHODS: First, for the entire Western United States (561 counties) for 2004-2009, we estimated daily PM2.5 concentrations directly attributable to wildfires (wildfires-specific PM2.5), using a global chemical transport model. Second, we defined smoke wave as ≥2 consecutive days with daily wildfire-specific PM2.5 > 20 μg/m, with sensitivity analysis considering 23, 28, and 37 μg/m. Third, we estimated the risk of cardiovascular and respiratory hospital admissions associated with smoke waves for Medicare enrollees. We used a generalized linear mixed model to estimate the relative risk of hospital admissions on smoke wave days compared with matched comparison days without wildfire smoke. RESULTS: We estimated that about 46 million people of all ages were exposed to at least one smoke wave during 2004 to 2009 in the Western United States. Of these, 5 million are Medicare enrollees (≥65 years). We found a 7.2% (95% confidence interval: 0.25%, 15%) increase in risk of respiratory admissions during smoke wave days with high wildfire-specific PM2.5 (>37 μg/m) compared with matched non smoke wave days. We did not observe an association between smoke wave days with wildfire-specific PM2.5 ≤ 37 μg/mand respiratory or cardiovascular admissions. Respiratory effects of wildfire-specific PM2.5 may be stronger than that of PM2.5 from other sources. CONCLUSION: Short-term exposure to wildfire-specific PM2.5was associated with risk of respiratory diseases in the elderly population in the Western United States during severe smoke days. See video abstract at, http://links.lww.com/EDE/B137.
Authors: Michelle L Bell; Keita Ebisu; Roger D Peng; Jonathan M Samet; Francesca Dominici Journal: Am J Respir Crit Care Med Date: 2009-03-19 Impact factor: 21.405
Authors: Roger D Peng; Michelle L Bell; Alison S Geyh; Aidan McDermott; Scott L Zeger; Jonathan M Samet; Francesca Dominici Journal: Environ Health Perspect Date: 2009-02-11 Impact factor: 9.031
Authors: Roger D Peng; Howard H Chang; Michelle L Bell; Aidan McDermott; Scott L Zeger; Jonathan M Samet; Francesca Dominici Journal: JAMA Date: 2008-05-14 Impact factor: 56.272
Authors: R J Delfino; S Brummel; J Wu; H Stern; B Ostro; M Lipsett; A Winer; D H Street; L Zhang; T Tjoa; D L Gillen Journal: Occup Environ Med Date: 2008-11-18 Impact factor: 4.402
Authors: Luxi Zhou; Kirk R Baker; Sergey L Napelenok; George Pouliot; Robert Elleman; Susan M O'Neill; Shawn P Urbanski; David C Wong Journal: Sci Total Environ Date: 2018-02-03 Impact factor: 7.963
Authors: Jia Coco Liu; Ander Wilson; Loretta J Mickley; Keita Ebisu; Melissa P Sulprizio; Yun Wang; Roger D Peng; Xu Yue; Francesca Dominici; Michelle L Bell Journal: Am J Epidemiol Date: 2017-09-15 Impact factor: 4.897
Authors: Marie McGee Hargrove; Yong Ho Kim; Charly King; Charles E Wood; M Ian Gilmour; Janice A Dye; Stephen H Gavett Journal: Inhal Toxicol Date: 2019-08-20 Impact factor: 2.724
Authors: Erin L Landguth; Zachary A Holden; Jonathan Graham; Benjamin Stark; Elham Bayat Mokhtari; Emily Kaleczyc; Stacey Anderson; Shawn Urbanski; Matt Jolly; Erin O Semmens; Dyer A Warren; Alan Swanson; Emily Stone; Curtis Noonan Journal: Environ Int Date: 2020-03-31 Impact factor: 9.621
Authors: Nam D Nguyen; Tosifa A Memon; Katherine L Burrell; Marysol Almestica-Roberts; Emmanuel Rapp; Lili Sun; Abigail F Scott; Joseph E Rower; Cassandra E Deering-Rice; Christopher A Reilly Journal: Mol Pharmacol Date: 2020-09-16 Impact factor: 4.436
Authors: Yuzhi Xi; Abhijit V Kshirsagar; Timothy J Wade; David B Richardson; M Alan Brookhart; Lauren Wyatt; Ana G Rappold Journal: J Am Soc Nephrol Date: 2020-07-16 Impact factor: 10.121